- Reduces inflammation in horses
- Alleviates pain in horses
- Non-steroidal; no adrenal suppression or steroid side effects.
- Fast acting. Active for up to 36 hrs
Possible Side Effects Injectable:
In horse, isolated reports of local reactions following intramuscular injection, particularly in the neck, have been received. These include localized swelling, sweating, induration, and stiffness. In rare instances in horses, fatal or nonfatal clostridial infections or other infections have been reported in association with intramuscular use of flunixin meglumine. In horses and cattle, rare instances of anaphylactic-like reactions, some of which have been fatal, have been reported, primarily following intravenous use.
Horse: The effect of BANAMINE Injectable Solution on pregnancy has not been determined. Studies to determine activity of BANAMINE Injectable Solution when administered concomitantly with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy.
Cattle: Do not use in bulls intended for breeding, as reproductive effects of Banamine Injectable Solution in these classes of cattle have not been investigated. NSAIDs are known to have potential effects on both parturition (See Contraindications) and the estrous cycle. There may be a delay in the onset of estrus if flunixin is administered during the prostaglandin phase of the estrous cycle. NSAIDs are known to have the potential to delay parturition through a tocolytic effect. The use of NSAIDs in the immediate post-partum period may interfere with uterine involution and expulsion of fetal membranes. Cows should be monitored carefully for placental retention if Banamine Injectable Solution is used within 24 hours after parturition.
The effect of BANAMINE Paste on pregnancy has not been determined. Studies to date show there is no detrimental effect on stallion spermatogenesis with or following the recommended dose of BANAMINE Paste.
Store between 2° and 30°C (36° and 86°F).
Store between 2° and 30°C (36° and 86°F).
DOSE AND ADMINISTRATION:
Horse: The recommended dose for musculoskeletal disorders is 0.5 mg per pound 1ML/100lbs of body weight once daily.
Treatment may be given by intravenous or intramuscular injection and repeated for up to 5 days. Studies show onset of activity is within 2 hours.
Peak response occurs between 12 and 16 hours and duration of activity is 24-36 hours.
The recommended dose for the alleviation of pain associated with equine colic is 0.5 mg per pound of body weight.
Intravenous administration is recommended for prompt relief.
Clinical studies show pain is alleviated in less than 15 minutes in many cases.
Treatment may be repeated when signs of colic recur.
During clinical studies approximately 10% of the horses required one or two additional treatments.
The cause of colic should be determined and treated with concomitant therapy.
The recommended dose for control of pyrexia associated with bovine respiratory disease and endotoxemia and control of inflammation in endotoxemia, is 1.1 to 2.2 mg/kg 0.5 to 1 mg/lb 1 to 2 mL per 100 lbs of body weight given by slow intravenous administration either once a day as a single dose or divided into two doses administered at 12-hour intervals for up to 3 days.
The total daily dose should not exceed 2.2 mg/kg 1.0 mg/lb of body weight. Avoid rapid intravenous administration of the drug.
The recommended dose for acute bovine mastitis is 2.2 mg/kg 1 mg/lb 2mL per 100 lbs of body weight given once by intravenous administration.
Cattle must not be slaughtered for human consumption within 4 days of the last treatment. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Not for use in dry dairy cows. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Not for use in horses intended for food.
Banamine Oral Paste:
DOSAGE AND ADMINISTRATION:
The recommended dose of flunixin is 0.5 mg per lb of body weight once daily. The BANAMINE Paste syringe, calibrated in twelve 250-lb weight increments, delivers 125 mg of flunixin for each 250 lbs see dosage table. One syringe will treat a 1000-lb horse once daily for 3 days, or three 1000-lb horses one time. *Use dial edge nearest syringe barrel to mark dose. The paste is orally administered by inserting the nozzle of the syringe through the interdental space, and depositing the required amount of paste on the back of the tongue by depressing the plunger. Treatment may be given initially by intravenous or intramuscular injection of BANAMINE Solution, followed by BANAMINE Granules or BANAMINE Paste on days 2 to 5. BANAMINE treatment should not exceed 5 consecutive days.
Not for use in horses intended for food.
Each milliliter of BANAMINE Injectable Solution contains:
flunixin meglumine equivalent to 50 mg flunixin, 0.1 mg edetate disodium, 2.5 mg sodium formaldehyde sulfoxylate, 4.0 mg diethanolamine, 207.2 mg propylene glycol 5.0 mg phenol as preservative, hydrochloric acid, water for injection qs.
Banamine Paste Contains:
Each 30-gram syringe of BANAMINE Paste contains flunixin meglumine equivalent to 1500 mg flunixin